|
| |
| Drug Development |
|
ReceptoPharm is developing proprietary
therapeutic protein products for the treatment of neurological,
viral and and autoimmune disorders. |
| »
Learn More |
|
|
| |
| CRO Services |
ReceptoPharm offers a full range of contract
research services catering to small and start-up biotech companies. |
| » Learn More |
|
|
|
Below you will find the most recent ReceptoPharm
press releases. To view press releases from
previous years, please visit the Archives.
February 02, 2010
Nutra Pharma Announces Fourth Quarter Sales for its Over-the-Counter (OTC) Pain Reliever, Cobroxin
December 07, 2009
Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx - Over-the-Counter and Prescription Treatments for Chronic Pain
December 03, 2009
Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain
November 19, 2009
Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution
October 14, 2009
Nutra Pharma Announces Online Availability of Cobroxin for the Treatment of Moderate to Severe Chronic Pain
October 07, 2009
Nutra Pharma Announces Nyloxin Rx, a Prescription Analgesic for the Treatment of Severe (Stage 3) Chronic Pain
October 02, 2009
Nutra Pharma Announces Manufacturing Release of Cobroxin, a Treatment for Chronic Pain
September 21, 2009
Nutra Pharma Announces Plans to Begin Drug Registration Process in Canada and Europe for its Over-the-Counter Pain Reliever
August 31, 2009
Nutra Pharma's Recently Launched Pain Reliever, Cobroxin, Wins "Best New Product" Award at Retailing Conference
August 26, 2009
Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain
|
|
|
|
| |
| E-Alerts
|
| Signup to receive news and announcements
from ReceptoPharm and Nutra Pharma: |
|
|
|
|
|
|
|
